Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Study of Tilsotolimod in Combination With Nivolumab and Ipilimumab for the Treatment of Solid Tumors (ILLUMINATE-206)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)
- Status
- RECRUITING
- Phase
- N/A
A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Identifying Novel Biomarkers in Early Rheumatology Patients
- Status
- UNKNOWN
- Phase
- N/A
Electronic and Lab Pre-screening of New Rheumatology Patients With Rheumatoid Arthritis
- Status
- UNKNOWN
- Phase
- N/A
Neoadjuvant Nivolumab for Oral Cancer Combined With FDG and Anti-PD-L1 PET/CT Imaging for Response Prediction
- Status
- UNKNOWN
- Phase
- PHASE1
Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation
- Status
- TERMINATED
- Phase
- PHASE3
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
- Status
- COMPLETED
- Phase
- PHASE1
A Trial of AVID200, a Transforming Growth Factor β (TGFβ) Inhibitor, in Patients Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability Study of AVID200 in Pts With Diffuse Cutaneous Systemic Sclerosis
- Status
- COMPLETED
- Phase
- PHASE1
SD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES)
- Status
- TERMINATED
- Phase
- PHASE2
Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO
- Status
- RECRUITING
- Phase
- PHASE2
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
- Status
- TERMINATED
- Phase
- EARLY_PHASE1